MediFind
Condition

Urothelial Cancer

Symptoms, Doctors, Treatments, Research & More

Latest Research

Latest Advance
Study
  • Condition: High Risk Upper Tract Urothelial Carcinoma with Cardiovascular Comorbidity
  • Journal: Scientific reports
  • Treatment Used: Adjuvant Chemotherapy after Radical Nephroureterectomy
  • Number of Patients: 176
  • Published —
This study tested the safety and efficacy of using adjuvant chemotherapy after radical nephroureterectomy to treat patients with high risk upper tract urothelial carcinoma with cardiovascular comorbidity.
Latest Advance
Study
  • Condition: Metastatic, Platinum-Treated Urothelial Carcinoma
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Avelumab
  • Number of Patients: 249
  • Published —
This study tested the safety and efficacy of using avelumab to treat patients with metastatic, platinum-treated urothelial carcinoma.
Latest Advance
Study
  • Condition: Urothelial Carcinoma
  • Journal: The New England journal of medicine
  • Treatment Used: Avelumab Maintenance Therapy
  • Number of Patients: 700
  • Published —
The study researched the outcomes of avelumab maintenance therapy for patients with advanced or metastatic urothelial carcinoma.
Latest Advance
Study
  • Condition: Urothelial Carcinoma
  • Journal: BMC cancer
  • Treatment Used: 5?-Reductase Inhibitors
  • Number of Patients: 18530
  • Published —
In this study, researchers evaluated the outcomes of using 5?-reductase inhibitors in the treatment of urothelial carcinoma.
Latest Advance
Study
  • Condition: Progressive Sarcomatoid Renal Cell Carcinoma
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Second-Line Nivolumab after Surgery
  • Number of Patients: 1
  • Published —
The study researched the outcomes of second-line nivolumab after surgery for progressive sarcomatoid renal cell carcinoma.
Latest Advance
Study
  • Condition: Miliary Pulmonary Tuberculosis
  • Journal: Revue medicale de Liege
  • Treatment Used: Intravesical Bacillus Calmette-Guerin (BCG) Instillation therapy
  • Number of Patients: 1
  • Published —
This case report describes a 74-year-old male who developed pulmonary granulomatosis secondary to intravesical Bacillus Calmette-Guerin (BCG) instillation therapy.
Latest Advance
Study
  • Condition: Urothelial Bladder Carcinoma
  • Journal: The Pan African medical journal
  • Treatment Used: Carcinologic complete resection
  • Number of Patients: 1
  • Published —
The study researched the outcomes of carcinologic complete resection in patients with urothelial bladder carcinoma.
Latest Advance
Study
  • Condition: Bladder Tumors
  • Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
  • Treatment Used: Needle Electrode in Transurethral Plasmakinetic Resection
  • Number of Patients: 16
  • Published —
The study researched the outcomes of needle electrode in transurethral plasmakinetic resection for bladder tumors.
Latest Advance
Study
  • Condition: Advanced Renal Pelvis Carcinoma with Lung Metastasis
  • Journal: Annals of palliative medicine
  • Treatment Used: Durvalumab Immunotherapy
  • Number of Patients: 1
  • Published —
This case report describes a 64-year-old patient with renal pelvis carcinoma who developed lung metastasis treated with PD-L1 monoclonal antibody (Durvalumab) alone.
Latest Advance
Study
  • Condition: Advanced Urothelial Carcinoma
  • Journal: Hinyokika kiyo. Acta urologica Japonica
  • Treatment Used: Platinum-based Chemotherapy
  • Number of Patients: 39
  • Published —
In this study, researchers evaluated the outcomes of different numbers of cycles of platinum-based chemotherapy for the treatment of advanced urothelial carcinoma.
Latest Advance
Study
  • Condition: Urothelial Carcinoma (UC) of Bladder with Abundant Myxoid Stroma
  • Journal: Medicine
  • Treatment Used: Laparoscopic Radical Cystectomy and Cutaneous Ureterostomy
  • Number of Patients: 1
  • Published —
This case report describes an 83-year-old woman diagnosed with urothelial carcinoma of the bladder with abundant myxoid stroma treated with laparoscopic radical cystectomy (bladder removal) and cutaneous ureterostomy.
Latest Advance
Study
  • Condition: Patients with Renal Insufficiency and Mixed Variant Histology (MVH)
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Atezolizumab
  • Number of Patients: 218
  • Published —
This study reported the safety and effectiveness of atezolizumab in patients with renal insufficiency or urothelial carcinoma (UC) with mixed variant histology (MVH).